Treatment Algorithms Dyslipidemia Statin monotherapies dominate the market but uncontrolled lipid levels remain an issue

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Arrhythmia Research Technology, Inc.

Arrhythmia Research Technology, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 56 pages

A textual analysis of the financial results for Arrhythmia Research Technology, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pathology

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

  • $ 4 995
  • Industry report
  • by GBI Research
  • September 2014
  • 96 pages

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting Summary GBI Research, the leading business intelligence provider, has released its latest research, ‘Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets ...

Industries: Pathology | Countries: World, Australia, India, Japan, China

World Pathology: Arrhythmias - Pipeline Review, H2 2011

World Pathology: Arrhythmias - Pipeline Review, H2 2011

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 40 pages

This report provides information on the therapeutic development for Arrhythmias, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Arrhythmias. '' is built using data and information sourced ...

Industries: Pathology | Countries: World

World Pathology: Influenza B Infections - Pipeline Review, H2 2011

World Pathology: Influenza B Infections - Pipeline Review, H2 2011

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 49 pages

This report provides information on the therapeutic development for Influenza B Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Influenza B Infections. '' is built using data ...

Industries: Pathology | Countries: World

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 90 pages

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014', provides an overview of the Recurrent Head And Neck Cancer Squamous Cell Carcinoma's therapeutic pipeline. ...

Industries: Pathology | Countries: World

Polycystic Ovarian Syndrome - Pipeline Review, H2 2014

Polycystic Ovarian Syndrome - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 45 pages

Polycystic Ovarian Syndrome - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Polycystic Ovarian Syndrome - Pipeline Review, H2 2014', provides an overview of the Polycystic Ovarian Syndrome's therapeutic pipeline. This report provides comprehensive information on the therapeutic development ...

Industries: Pathology | Countries: World

Anaplastic Thyroid Cancer - Pipeline Review, H2 2014

Anaplastic Thyroid Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 81 pages

Anaplastic Thyroid Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Anaplastic Thyroid Cancer - Pipeline Review, H2 2014', provides an overview of the Anaplastic Thyroid Cancer's therapeutic pipeline. This report provides comprehensive information on the therapeutic development fo ...

Industries: Pathology | Countries: World

Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2014

Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 46 pages

Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2014', provides an overview of the Functional (Non Ulcer) Dyspepsia's therapeutic pipeline. This report provides comprehensive information on the therapeutic ...

Industries: Pathology | Countries: World

Herpes Zoster (Shingles) - Pipeline Review, H2 2014

Herpes Zoster (Shingles) - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 61 pages

Herpes Zoster (Shingles) - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Herpes Zoster (Shingles) - Pipeline Review, H2 2014', provides an overview of the Herpes Zoster (Shingles)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development fo ...

Industries: Pathology | Countries: World

Premature Ejaculation - Pipeline Review, H2 2014

Premature Ejaculation - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 66 pages

Premature Ejaculation - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Premature Ejaculation - Pipeline Review, H2 2014', provides an overview of the Premature Ejaculation's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Premature ...

Industries: Pathology | Countries: World, Canada

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.